Opes Wealth Management Reduces Johnson & Johnson Holdings

Firm sells over 5,000 shares of healthcare giant in Q3

Mar. 19, 2026 at 9:20am

Got story updates? Submit your updates here. ›

Opes Wealth Management LLC reduced its holdings in Johnson & Johnson (NYSE:JNJ) by 42.7% in the 3rd quarter, according to the company's most recent SEC filing. The firm now owns 6,968 shares of the company's stock, down from 12,169 shares previously.

Why it matters

Johnson & Johnson is one of the largest and most widely held healthcare companies, so changes in institutional ownership can provide insights into investor sentiment around the stock.

The details

Opes Wealth Management sold 5,201 shares of Johnson & Johnson during the quarter, reducing its total position to 6,968 shares worth approximately $1.29 million as of the latest filing. The firm cited portfolio rebalancing and other investment considerations as reasons for the reduced stake in the healthcare conglomerate.

  • Opes Wealth Management reduced its Johnson & Johnson holdings in the 3rd quarter of 2026.

The players

Opes Wealth Management LLC

A financial advisory firm that manages investments for its clients.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

This filing shows that at least one institutional investor has reduced its exposure to the healthcare giant, though the reasons behind the portfolio change are not entirely clear. Investors will likely continue to monitor institutional ownership trends for clues about the market's broader sentiment on Johnson & Johnson.